Opposing electrophysiological actions of 5-HT on noncholinergic and cholinergic neurons in the rat ventral pallidum in vitro

Journal of Neurophysiology

Volumn 92, Issue 1, 2004, Pages 433-443

  Bengtson, C Peter ^a   Lee, David J ^b   Osborne, Peregrine B ^a,b,c  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 3 [2 [2 (4 METHYL 1 PIPERIDINYL)ETHYL] 1 PYRROLIDINESULFONYL]PHENOL; 5 CARBAMOYLTRYPTAMINE; 5 METHOXYTRYPTAMINE; ADENYLATE CYCLASE; CESIUM; CLOZAPINE; CYCLIC AMP; FORSKOLIN; MIANSERIN; PIMOZIDE; PINDOLOL; POSTSYNAPTIC RECEPTOR; POTASSIUM CHANNEL; RECEPTOR SUBTYPE; SEROTONIN; SEROTONIN 1 RECEPTOR; SEROTONIN 7 RECEPTOR; SEROTONIN RECEPTOR;

ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CHOLINERGIC NERVE CELL; CONTROLLED STUDY; DORSAL RAPHE NUCLEUS; ELECTROPHYSIOLOGY; FOREBRAIN; GLOBUS PALLIDUS; H CURRENT; HYPERPOLARIZATION; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; INWARD CURRENT; LIMBIC CORTEX; MAGNOCELLULAR NUCLEUS; MEMBRANE CURRENT; NERVE PROJECTION; NONCHOLINERGIC NERVE CELL; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; RAT; SEROTONINERGIC NERVE; VENTRAL PALLIDUM;

ACTION POTENTIALS; ANIMALS; CHOLINERGIC FIBERS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHYSIOLOGY; GLOBUS PALLIDUS; RATS; RATS, WISTAR; SEROTONIN;

EID: 3042681358     PISSN: 00223077     EISSN: None     Source Type: Journal    
DOI: 10.1152/jn.00543.2003     Document Type: Article

References (73)

1. Adham N, Zgombick JM, Bard J, and Branchek TA. Functional characterization of the recombinant human 5-hydroxytryptamine7(a) receptor isoform coupled to adenylate cyclase stimulation. J Pharmacol Exp Ther 287: 508-514, 1998.
2. 1c receptors in rat brain. J Pharmacol Exp Ther 255: 843-857, 1990.
3. Barnes NM and Sharp T. A review of central 5-HT receptors and their function. Neuropharmacology 38: 1083-1152, 1999.
4. Barry PH. Jpcalc, a software package for calculating liquid junction potential corrections in patch-clamp, intracellular, epithelial and bilayer measurements and for correcting junction potential measurements. J Neurosci Methods 51: 107-116, 1994.
5. Bengtson CP and Osborne PB. Electrophysiological properties of cholinergic and noncholinergic neurons in the ventral pallidal region of the nucleus basalis in rat brain slices. J Neurophysiol 83: 2649-2660, 2000.
6. Bevan MD, Magill PJ, Terman D, Bolam JP, and Wilson CJ. Move to the rhythm: oscillations in the subthalamic nucleus-external globus pallidus network. Trends Neurosci 25: 525-531, 2002.
7. h in central neurons. Neuron 2: 1535-1540, 1989.
8. 6 receptors stably expressed in hek293 cells. Neuropharmacology 36: 713-720, 1997.
9. 1A/1B double-knockout mice. J Pharmacol Exp Ther 302: 240-248, 2002.
10. Cardenas CG, Mar LP, Vysokanov AV, Arnold PB, Cardenas LM, Surmeier DJ, and Scroggs RS. Serotonergic modulation of hyperpolarization-activated current in acutely isolated rat dorsal root ganglion neurons. J Physiol 518: 507-523, 1999.
11. Carlsen J, Zaborszky L, and Heimer L. Cholinergic projections from the basal forebrain to the basolateral amygdaloid complex: a combined retrograde fluorescent and immunohistochemical study. J Comp Neurol 234: 155-167, 1985.
12. h. J Pharmacol Exp Ther 297: 403-409, 2001a.
13. 7 receptor-mediated depolarization in the anterodorsal thalamus. I. Pharmacological characterization. J Pharmacol Exp Ther 297: 395-402, 2001b.
14. Detari L, Rasmusson DD, and Semba K. The role of basal forebrain neurons in tonic and phasic activation of the cerebral cortex. Prog Neurobiol 58: 249-277, 1999.
15. 7 receptor: orphan found. Trends Pharmacol Sci 18: 104-107, 1997.
16. Gasbarri A, Sulli A, Pacitti C, and McGaugh JL. Serotonergic input to cholinergic neurons in the substantia innominata and nucleus basalis magnocellularis in the rat. Neuroscience 91: 1129-1142, 1999.
17. 4 receptor: molecular cloning and pharmacological characterization of two splice variants. EMBO J 14: 2806-2815, 1995.
18. Gorelova N and Reiner PB. Role of the afterhyperpolarization in control of discharge properties of septal cholinergic neurons in vitro. J Neurophysiol 75: 695-706, 1996.
19. 6 mRNA in the rat brain during ontogenetic development. Naunyn Schmiedebergs Arch Pharmacol 357: 393-400, 1998.
20. Gritti I, Mainville L, and Jones BE. Codistribution of GABA- with acetylcholine-synthesizing neurons in the basal forebrain of the rat. J Comp Neurol 329: 438-457, 1993.
21. Groenewegen HJ, Berendse HW, and Haber SN. Organization of the output of the ventral striatopallidal system in the rat: ventral pallidal efferents. Neuroscience 57: 113-142, 1993.
22. 7 receptor in rat brain. Br J Pharmacol 117: 657-666, 1996.
23. 1B ligands on ventral pallidal neuronal activity. Neuroreport 11: 2849-2853, 2000.
24. 7) receptor isoforms produced by alternative splicing. Neuropharmacology 37: 1621-1632, 1998.
25. Heimer L, Harlan RE, Alheid GF, Garcia MM, and de Olmos J. Substantia innominata: a notion which impedes clinical-anatomical correlations in neuropsychiatric disorders. Neuroscience 76: 957-1006, 1997.
26. Hoyer D, Clarke DE, Fozard JR, Hartig PR, Martin GR, Mylecharane EJ, Saxena PR, and Humphrey PP. International union of pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol Rev 46: 157-203, 1994.
27. Ingham CA, Bolam JP, Wainer BH, and Smith AD. A correlated light and electron microscopic study of identified cholinergic basal forebrain neurons that project to the cortex in the rat. J Comp Neurol 239: 176-192, 1985.
28. 7B). Br J Pharmacol 122: 126-132, 1997.
29. 2 receptor subtypes. Eur J Pharmacol 414: 23-30, 2001.
30. Joel D and Weiner I. The connections of the dopaminergic system with the striatum in rats and primates: an analysis with respect to the functional and compartmental organization of the striatum. Neuroscience 96: 451-474, 2000a.
31. Joel D and Weiner I. Striatal contention scheduling and the split circuit scheme of basal ganglia-thalamocortical circuitry: from anatomy to behaviour. In: Brain Dynamics and the Striatal Complex, edited by Miller R and Wickens J. Sydney, Australia: Harwood Academic, 2000b.
32. Jones BE and Cuello AC. Afferents to the basal forebrain cholinergic cell area from pontomesencephalic-catecholamine, serotonin, and acetylcholine- neurons. Neuroscience 31: 37-61, 1989.
33. Kalivas PW and Nakamura M. Neural systems for behavioral activation and reward. Curr Opin Neurobiol 9: 223-227, 1999.
34. Khateb A, Fort P, Alonso A, Jones BE, and Muhlethaler M. Pharmacological and immunohistochemical evidence for serotonergic modulation of cholinergic nucleus basalis neurons. Eur J Neurosci 5: 541-547, 1993.
35. 7 receptor splice variants: a comparative characterization of their pharmacology, function and distribution. Naunyn Schmiedebergs Arch Pharmacol 363: 620-632, 2001.
36. Lavin A and Grace AA. Physiological properties of rat ventral pallidal neurons recorded intracellularly in vivo. J Neurophysiol 75: 1432-1443, 1996.
37. Lucas-Meunier E, Fossier P, Baux G, and Amar M. Cholinergic modulation of the cortical neuronal network. Pfluegers Arch 446: 17-29, 2003.
38. Maurice N, Deniau JM, Menetrey A, Glowinski J, and Thierry AM. Position of the ventral pallidum in the rat prefrontal cortex-basal ganglia circuit. Neuroscience 80: 523-534, 1997.
39. Mayer ML and Westbrook GL. A voltage-clamp analysis of inward (anomalous) rectification in mouse spinal sensory ganglion neurones. J Physiol 340: 19-45, 1983.
40. McCormick DA and Pape HC. Properties of a hyperpolarization-activated cation current and its role in rhythmic oscillation in thalamic relay neurones. J Physiol 431: 291-318, 1990.
41. McKinney M, Coyle JT, and Hedreen JC. Topographic analysis of the innervation of the rat neocortex and hippocampus by the basal forebrain cholinergic system. J Comp Neurol 217: 103-121, 1983.
42. Mesulam MM, Mufson EJ, Wainer BH, and Levey AI. Central cholinergic pathways in the rat: an overview based on an alternative nomenclature (Ch1-Ch6). Neuroscience 10: 1185-1201, 1983.
43. Mitrovic I and Napier TC. Electrophysiological demonstration of mu, delta and kappa opioid receptors in the ventral pallidum. J Pharmacol Exp Ther 272: 1260-1270, 1995.
44. Mitrovic I and Napier TC. Interactions between the mu opioid agonist DAMGO and substance P in regulation of the ventral pallidum. Synapse 23: 142-151, 1996.
45. 1 and D2 dopamine receptors within the ventral pallidum. Synapse 17: 160-166, 1994.
46. Napier TC and Potter PE. Dopamine in the rat ventral pallidum/substantia innominata: biochemical and electrophysiological studies. Neuropharmacology 28: 757-760, 1989.
47. Napier TC, Simson PE, and Givens BS. Dopamine electrophysiology of ventral pallidal/substantia innominata neurons: comparison with the dorsal globus pallidus. J Pharmacol Exp Ther 258: 249-262, 1991.
48. 7 receptors in rat brain by immunocytochemistry, in situ hybridization, and agonist stimulated cFos expression. J Chem Neuroanat 21: 63-73, 2001.
49. 1A receptor binding sites in rat cortex, hippocampus and cholinergic basal forebrain nuclei during aging. J Chem Neuroanat 13: 53-61, 1997.
50. 5A receptor-like immunoreactivity in the rat brain. Brain Res 867: 131-142, 2000.
51. 1A receptor in the rat brain: correlation with receptor binding. J Neurosci 12: 440-453, 1992.
52. Proenza C, Angoli D, Agranovich E, Macri V, and Accili EA. Pacemaker channels produce an instantaneous current. J Biol Chem 277: 5101-5109, 2002.
53. Raymond JR, Mukhin YV, Gelasco A, Turner J, Collinsworth G, Gettys TW, Grewal JS, and Garnovskaya MN. Multiplicity of mechanisms of serotonin receptor signal transduction. Pharmacol Ther 92: 179-212, 2001.
54. Richelson E and Souder T. Binding of antipsychotic drugs to human brain receptors focus on newer generation compounds. Life Sci 68: 29-39, 2000.
55. Roberts C, Price GW, and Middlemiss DN. Ligands for the investigation of 5-HT autoreceptor function. Brain Res Bull 56: 463-469, 2001.
56. Roth BL, Craigo SC, Choudhary MS, Uluer A, Monsma FJ Jr, Shen Y, Meltzer HY, and Sibley DR. Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors. J Pharmacol Exp Ther 268: 1403-1410, 1994.
57. 1B receptors in the rat central nervous system: immunocytochemical, autoradiographic and lesion studies. Neuroscience 88: 899-915, 1999.
58. Sizemore GM, Co C, and Smith JE. Ventral pallidal extracellular fluid levels of dopamine, serotonin, gamma amino butyric acid, and glutamate during cocaine self-administration in rats. Psychopharmacology (Berl) 150: 391-398, 2000.
59. Sleight AJ, Boess FG, Bos M, and Bourson A. The putative 5-HT6 receptor: localization and function. Ann NY Acad Sci 861: 91-96, 1998.
60. Smiley JF, Subramanian M, and Mesulam M-M. Monoaminergic-cholinergic interactions in the primate basal forebrain. Neuroscience 93: 817-829, 1999.
61. 35S]gtp gamma s binding. Eur J Pharmacol 320: 267-275, 1997.
62. Sur C, Betz H, and Schloss P. Immunocytochemical detection of the serotonin transporter in rat brain. Neuroscience 73: 217-231, 1996.
63. Swanson LW. Cerebral hemisphere regulation of motivated behavior. Brain Res 886: 113-164, 2000.
64. Takahashi T and Berger AJ. Direct excitation of rat spinal motoneurones by serotonin. J Physiol 423: 63-76, 1990.
65. 7 receptors in guinea-pig brain. Br J Pharmacol 115: 107-116, 1995.
66. 4 receptor mRNA in the rat brain. Naunyn Schmiedebergs Arch Pharmacol 354: 210-212, 1996.
67. Vertes RP. A PHA-1 analysis of ascending projections of the dorsal raphe nucleus in the rat. J Comp Neurol 313: 643-668, 1991.
68. 4 receptor mRNA in rat brain by in situ hybridization histochemistry. Mol Brain Res 43: 356-360, 1996.
69. 3H]5-carboxamidotryptamine binding sites in the guinea pig and rat brain. Eur J Pharmacol 283: 31-46, 1995.
70. Williams S, Serafin M, Muhlethaler M, and Bernheim L. The serotonin inhibition of high-voltage-activated calcium currents is relieved by action potential-like depolarizations in dissociated cholinergic nucleus basalis neurons of the guinea-pig. Eur J Neurosci 10: 3291-3294, 1998.
71. Wright DE, Seroogy KB, Lundgren KH, Davis BM, and Jennes L. Comparative localization of serotonin la, lc, and 2 receptor subtype mRNAs in rat brain. J Comp Neurol 351: 357-373, 1995.
72. Zahm DS and Heimer L. Two transpallidal pathways originating in the rat nucleus accumbens. J Comp Neurol 302: 437-446, 1990.
73. 1D receptors. Neuropharmacology 36: 513-524, 1997.